Поиск | MyLiveRoom

Harshasharma Harshasharma добавлена новая статья Networking
2026-01-14 07:27:17 - Перевод -

Aflibercept Market: Insights and Competitive Analysis
Market Trends Shaping Executive Summary Aflibercept Market Size and Share CAGR Value Data Bridge Market Research analyses that the aflibercept market which was USD 8,343.15 million in 2022, and would rocket up to USD 13,911.94 million by 2030, and is expected to undergo a CAGR of 5.40% during the forecast period. Aflibercept report has been formulated by keeping in mind all the...

0 Комментарии 0 Поделились 901 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Data Bridge добавлена новая статья Другое
2025-08-18 08:00:10 - Перевод -

Aflibercept Market : Trends, Forecast, and Competitive Landscape 2025 –2032
"Executive Summary Aflibercept Market Opportunities by Size and Share CAGR Value Data Bridge Market Research analyses that the aflibercept market which was USD 8,343.15 million in 2022, and would rocket up to USD 13,911.94 million by 2030, and is expected to undergo a CAGR of 5.40% during the forecast period. An international Aflibercept Market report lends a hand to identify how...

0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Harshasharma Harshasharma добавлена новая статья Другое
2026-03-04 06:14:25 - Перевод -

Aflibercept Market: Insights and Competitive Analysis
Executive Summary Aflibercept Market Size and Share Analysis Report CAGR Value Data Bridge Market Research analyses that the aflibercept market which was USD 8,343.15 million in 2022, and would rocket up to USD 13,911.94 million by 2030, and is expected to undergo a CAGR of 5.40% during the forecast period. The global Aflibercept Market research report has incorporated the...

0 Комментарии 0 Поделились 210 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Rishika Datta добавлена новая статья Другое
2026-03-13 10:10:59 - Перевод -

VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology Therapies
According to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...

0 Комментарии 0 Поделились 828 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!